• Genhtis GmbH
  • Am Klopferspitz 19
  • 82152 Planegg/Martinsried
  • Germany
  • moc.sithneg@ofni
Johann Körner, CTO (links) und Arthur Körner, Co-Founder

Johann Körner, CTO (left) and Arthur Körner, Co-Founder

About Genhtis

Genhtis is a biotechnology company headquartered in Mügeln, Saxony, with an additional presence at the Innovation and Start-up Center for Biotechnology (IZB) in Planegg/Martinsried near Munich. The company was founded to develop and translate innovative biotechnological processes into industrial applications.

Its core focus lies in the research, development, and optimization of advanced, science-driven production technologies. Genhtis combines deep expertise in biochemistry with strong business acumen to align technological innovation with a clear strategic and commercial vision.

The interdisciplinary team is committed to building scalable solutions that address current and future industry requirements. As part of the IZB ecosystem, Genhtis benefits from close proximity to leading research institutions, high-growth biotechnology ventures, and established life sciences companies within the Munich biotech cluster.

What is your motivation?

Genhtis is driven by the conviction that biotechnological innovations can make a meaningful contribution to improving existing manufacturing processes. Our goal is to develop sustainable and efficient solutions that have a lasting positive impact on various areas of the life sciences industry. We believe that modern approaches in biotechnology can help advance established processes while considering both ecological and economic aspects. Our team brings together diverse competencies and works to explore new pathways for addressing existing challenges in the broader field of applied life sciences. In doing so, we rely on scientific diligence and a deep understanding of the relevant technologies and their potential applications. The opportunity to be part of a dynamic community of companies at IZB reinforces our commitment to advancing innovative concepts and developing them further for the benefit of the industry.

“IZB provides us with the ideal environment to further develop our ideas in an innovative and scientifically driven setting, and to benefit from a strong and supportive network of like-minded companies.”

Johann Körner, CTO and Arthur Körner, Co-Founder